Overview

The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

Status:
Completed
Trial end date:
2018-08-17
Target enrollment:
Participant gender:
Summary
This is a 24-week study to evaluate the effects of two fixed-dose combinations of leucine and sildenafil or two fixed-dose combinations of leucine, sildenafil and metformin compared to placebo. The primary objective of this study is to evaluate the percentage change in body weight in subjects from Baseline/Visit 2 (Day 1) to Study Termination/Visit 8 (Day 168/Week 24).
Phase:
Phase 2
Details
Lead Sponsor:
NuSirt Biopharma